796
Views
44
CrossRef citations to date
0
Altmetric
Review

Extinction learning in childhood anxiety disorders, obsessive compulsive disorder and post-traumatic stress disorder: implications for treatment

, , , , &
Pages 1155-1174 | Received 31 Mar 2016, Accepted 03 Jun 2016, Published online: 27 Jun 2016

References

  • American Psychiatric Association. Diagnostic and statistic manual of mental disorders. Washington (DC): Author; 2000.
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). Arlington (VA): American Psychiatric Publishing; 2013.
  • Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593–602.
  • Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349(9063):1436–1442.
  • Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1575–1586.
  • Pine DS, Cohen P, Gurley D, et al. The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Arch Gen Psychiatry. 1998;55(1):56–64.
  • Walkup JT, Albano AM, Piacentini J, et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med. 2008;359(26):2753–2766.
  • (POTS) POTS. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. Jama. 2004;292(16):1969–1976.
  • McGuire JF, Piacentini J, Lewin AB, et al. A meta-analysis of cognitive behavior therapy and medication for child obsessive-compulsive disorder: moderators of treatment efficacy, response and remission. Depress Anxiety. 2015;32(8):580–593.
  • Geller D, March J. Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Adolesc Psychiatry. 2012;51(1):98–113.
  • Bloch MH, Storch EA. Assessment and management of treatment-refractory obsessive-compulsive disorder in children. J Am Acad Adolesc Psychiatry. 2015;54(4):251–262.
  • Piacentini J, Bergman RL, Chang S, et al. Controlled comparison of family cognitive behavioral therapy and psychoeducation/relaxation training for child obsessive-compulsive disorder. J Am Acad Adolesc Psychiatry. 2011;50(11):1149–1161.
  • Storch EA, Bussing R, Small BJ, et al. Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive–compulsive disorder. Behav Res Ther. 2013;51(12):823–829.
  • Ginsburg GS, Becker EM, Keeton CP, et al. Naturalistic follow-up of youths treated for pediatric anxiety disorders. JAMA Psychiatry. 2014;71(3):310–318.
  • McGuire JF, Lewin AB, Storch EA. Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder. Expert Rev Neurother. 2014;14(8):893–910.
  • Lewin AB, McGuire JF, Murphy TK, et al. Editorial Perspective: the importance of considering parent’s preferences when planning treatment for their children–the case of childhood obsessive‐compulsive disorder. J Child Psychol Psychiatry. 2014;55(12):1314–1316.
  • Brown AM, Deacon BJ, Abramowitz JS, et al. Parents’ perceptions of pharmacological and cognitive-behavioral treatments for childhood anxiety disorders. Behav Res Ther. 2007;45(4):819–828.
  • Fitzgerald PJ, Seemann JR, Maren S. Can fear extinction be enhanced? A review of pharmacological and behavioral findings. Brain Res Bull. 2014;105:46–60.
  • McGuire JF, Wu MS, Piacentini J, et al. A meta-analysis of D-cycloserine in exposure-based treatment: moderators of treatment efficacy, response, and diagnostic remission. J Clin Psychiatry. 2016. doi:10.4088/JCP.15r10334. [Epub ahead print].
  • Bontempo MA, Panza MKE, Bloch MH. Meta-analysis: D-cycloserine augmentation of behavioral therapy for the treatment of anxiety disorders. J Clin Psychiatry. 2012;73(4):533–537.
  • Smits JAJ, Rosenfield D, Otto MW, et al. D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions. J Psychiatr Res. 2013;47(10):1455–1461.
  • Rothbaum B, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for post-traumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014;171(6):640–648.
  • Byrne S, Rapee R, Richardson R, et al. D-cycloserine enhances generalization of fear extinction in children. Depress Anxiety. 2015;32:408–414.
  • Otto MW, Kredlow MA, Smits JA, et al. Enhancement of psychosocial treatment with d-cycloserine: models, moderators, and future directions. Biol Psychiatry. 2015. doi:10.1016/j.biopsych.2015.09.007. [Epub ahead of print].
  • Hofmann SG, Carpenter JK, Otto MW, et al. Dose timing of d-cycloserine to augment cognitive behavioral therapy for social anxiety: study design and rationale. Contemp Clin Trials. 2015;43:223–230.
  • Craske MG, Liao B, Brown L, et al. Role of inhibition in exposure therapy. J Exp Psychopathol. 2012;3(3):322–345.
  • Craske MG, Treanor M, Conway CC, et al. Maximizing exposure therapy: an inhibitory learning approach. Behav Res Ther. 2014;58:10–23.
  • Milad MR, Quirk GJ. Fear extinction as a model for translational neuroscience: ten years of progress. Annu Rev Psychol. 2012;63:129–151.
  • Pine DS. Integrating research on development and fear learning: a vision for clinical neuroscience? Depress Anxiety. 2009;26(9):775–779.
  • Beidel DC, Alfano CA. Child anxiety disorders: a guide to research and treatment. New York (NY): Taylor & Francis; 2011.
  • Lewin AB, Wu MS, McGuire JF, et al. Cognitive behavior therapy for obsessive-compulsive and related disorders. Psychiatr Clin North Am. 2014;37(3):415–445.
  • Duits P, Cath DC, Lissek S, et al. Updated meta-analysis of classical fear conditioning in the anxiety disorders. Depress Anxiety. 2015;32(4):239–253. .
  • Bouton M, Mineka S, Barlow D. A modern learning theory perspective on the etiology of panic disorder. Psychol Rev. 2001;108(1):4–32.
  • Pattwell SS, Duhoux S, Hartley CA, et al. Altered fear learning across development in both mouse and human. Proc Natl Acad Sci. 2012;109(40):16318–16323 .
  • Baker KD, Den ML, Graham BM, et al. A window of vulnerability: impaired fear extinction in adolescence. Neurobiol Learn Mem. 2014;113:90–100.
  • Farrell L, Barrett P, Piacentini J. Obsessive–compulsive disorder across the developmental trajectory: clinical correlates in children, adolescents and adults. Behaviour Change. 2006;23(02):103–120.
  • Geller DA, Biederman J, Faraone S, et al. Developmental aspects of obsessive compulsive disorder: findings in children, adolescents, and adults. J Nerv Ment Dis. 2001;189(7):471–477.
  • Lau JY, Britton JC, Nelson EE, et al. Distinct neural signatures of threat learning in adolescents and adults. Proc Natl Acad Sci. 2011;108(11):4500–4505.
  • Britton JC, Grillon C, Lissek S, et al. Response to learned threat: an fMRI study in adolescent and adult anxiety. Am J Psychiatry. 2013;170(10):1195–1204.
  • Casey B, Giedd JN, Thomas KM. Structural and functional brain development and its relation to cognitive development. Biol Psychol. 2000;54(1–3):241–257.
  • Somerville LH, Jones RM, Casey B. A time of change: behavioral and neural correlates of adolescent sensitivity to appetitive and aversive environmental cues. Brain Cogn. 2010;72(1):124–133.
  • Britton JC, Evans TC, Hernandez MV. Looking beyond fear and extinction learning: considering novel treatment targets for anxiety. Curr Behav Neurosci Rep. 2014;1(3):134–143.
  • Tolin DF, Worhunsky P, Maltby N. Sympathetic magic in contamination-related OCD. J Behav Ther Exp Psychiatry. 2004;35(2):193–205.
  • Torrents‐Rodas D, Fullana MA, Bonillo A, et al. Testing the temporal stability of individual differences in the acquisition and generalization of fear. Psychophysiology. 2014;51(7):697–705.
  • Grillon C. Startle reactivity and anxiety disorders: aversive conditioning, context, and neurobiology. Biol Psychiatry. 2002;52(10):958–975.
  • Iberico C, Vansteenwegen D, Vervliet B, et al. The development of cued versus contextual conditioning in a predictable and an unpredictable human fear conditioning preparation. Acta Psychol (Amst). 2008;127(3):593–600.
  • Bouton ME. Context, ambiguity, and unlearning: sources of relapse after behavioral extinction. Biol Psychiatry. 2002;52(10):976–986.
  • Myers KM, Davis M. Mechanisms of fear extinction. Mol Psychiatry. 2007;12(2):120–150.
  • Bouton ME, Bolles RC. Role of conditioned contextual stimuli in reinstatement of extinguished fear. J Exp Psychol Anim Behav Processes. 1979;5(4):368.
  • Morrow M, Boring F, Keough T, et al. Differential GSR conditioning as a function of age. Dev Psychol. 1969;1(4):299–302.
  • Block JD, Sersen EA, Wortis J. Cardiac classical conditioning and reversal in the mongoloid, encephalopathic, and normal child. Child Dev. 1970;41:771–785.
  • Neumann DL, Waters AM, Westbury HR. The use of an unpleasant sound as the unconditional stimulus in aversive Pavlovian conditioning experiments that involve children and adolescent participants. Behav Res Methods. 2008;40(2):622–625.
  • Neumann DL, Waters AM, Westbury HR, et al. The use of an unpleasant sound unconditional stimulus in an aversive conditioning procedure with 8-to 11-year-old children. Biol Psychol. 2008;79(3):337–342.
  • Gao Y, Raine A, Venables PH, et al. The development of skin conductance fear conditioning in children from ages 3 to 8 years. Dev Sci. 2010;13(1):201–212.
  • Haddad AD, Lissek S, Pine DS, et al. How do social fears in adolescence develop? Fear conditioning shapes attention orienting to social threat cues. Cogn Emot. 2011;25(6):1139–1147.
  • Glenn CR, Klein DN, Lissek S, et al. The development of fear learning and generalization in 8–13 year‐olds. Dev Psychobiol. 2012;54(7):675–684.
  • Chauret M, La Buissonnière-Ariza V, Tremblay VL, et al. The conditioning and extinction of fear in youths: what’s sex got to do with it? Biol Psychol. 2014;100:97–105.
  • Tzschoppe J, Nees F, Banaschewski T, et al. Aversive learning in adolescents: modulation by Amygdala–Prefrontal and Amygdala–hippocampal connectivity and neuroticism. Neuropsychopharmacology. 2014;39(4):875–884.
  • Waters AM, Peters R-M, Forrest KE, et al. Fear acquisition and extinction in offspring of mothers with anxiety and depressive disorders. Dev Cogn Neurosci. 2014;7:30–42.
  • Den ML, Graham BM, Newall C, et al. Teens that fear screams: a comparison of fear conditioning, extinction, and reinstatement in adolescents and adults. Dev Psychobiol. 2015;57(7):818–832.
  • Kadosh KC, Haddad AD, Heathcote LC, et al. High trait anxiety during adolescence interferes with discriminatory context learning. Neurobiol Learn Mem. 2015;123:50–57.
  • Michalska KJ, Shechner T, Hong M, et al. A developmental analysis of threat/safety learning and extinction recall during middle childhood. J Exp Child Psychol. 2016;146:95–105.
  • Schiele MA, Reinhard J, Reif A, et al. Developmental aspects of fear: comparing the acquisition and generalization of conditioned fear in children and adults. Dev Psychobiol. 2016;58:471–481.
  • Shechner T, Hong M, Britton JC, et al. Fear conditioning and extinction across development: evidence from human studies and animal models. Biol Psychol. 2014;100:1–12.
  • Allen KB, Allen B, Austin KE, et al. Synchrony–desynchrony in the tripartite model of fear: predicting treatment outcome in clinically phobic children. Behav Res Ther. 2015;71:54–64.
  • Pliszka SR, Hatch JP, Borcherding SH, et al. Classical conditioning in children with attention deficit hyperactivity disorder (ADHD) and anxiety disorders: a test of Quay’s model. J Abnorm Child Psychol. 1993;21(4):411–423.
  • Craske MG, Waters AM, Bergman RL, et al. Is aversive learning a marker of risk for anxiety disorders in children? Behav Res Ther. 2008;46(8):954–967.
  • Lau JYF, Lissek S, Nelson EE, et al. Fear conditioning in adolescents with anxiety disorders: Results from a novel experimental paradigm. J Am Acad Child Adolesc Psychiatry. 2008;47(1):94–102.
  • Waters AM, Henry J, Neumann DL. Aversive Pavlovian conditioning in childhood anxiety disorders: impaired response inhibition and resistance to extinction. J Abnormal Psychol. 2009;118(2):311–321.
  • Haddad AD, Bilderbeck A, James AC, et al. Fear responses to safety cues in anxious adolescents: preliminary evidence for atypical age-associated trajectories of functional neural circuits. J Psychiatr Res. 2015;68:301–308.
  • Shechner T, Britton JC, Ronkin EG, et al. Fear conditioning and extinction in anxious and nonanxious youth and adults: examining a novel developmentally appropriate fear-conditioning task. Depress Anxiety. 2015;32(4):277–288.
  • Waters AM, Kershaw R. Direction of attention bias to threat relates to differences in fear acquisition and extinction in anxious children. Behav Res Ther. 2015;64:56–65.
  • Liberman LC, Lipp OV, Spence SH, et al. Evidence for retarded extinction of aversive learning in anxious children. Behav Res Ther. 2006;44(10):1491–1502.
  • Waters AM, Pine DS. Evaluating differences in Pavlovian fear acquisition and extinction as predictors of outcome from cognitive behavioural therapy for anxious children. J Psychol Psychiatry. 2016. doi:10.1111/jcpp.12522. [Epub ahead of print].
  • McGuire JF, Orr SP, Wu MS, et al. Fear conditioning and extinction in youth with obsessive compulsive disorder. Depress Anxiety. 2016;33(3):229–237.
  • Jovanovic T, Nylocks KM, Gamwell KL, et al. Development of fear acquisition and extinction in children: effects of age and anxiety. Neurobiol Learn Mem. 2014;113:135–142.
  • Gamwell K, Nylocks M, Cross D, et al. Fear conditioned responses and PTSD symptoms in children: sex differences in fear‐related symptoms. Dev Psychobiol. 2015;57(7):799–808.
  • McLaughlin KA, Sheridan MA, Gold AL, et al. Maltreatment exposure, brain structure, and fear conditioning in children and adolescents. Neuropsychopharmacology. 2016;41:1956–1964.
  • De Los Reyes A. Introduction to the special section: more than measurement error: discovering meaning behind informant discrepancies in clinical assessments of children and adolescents. J Clin Adolesc Psychol. 2011;40(1):1–9.
  • Kircanski K, Peris TS. Exposure and response prevention process predicts treatment outcome in youth with ocd. J Abnorm Child Psychol. 2015;43:543–552.
  • Kircanski K, Wu M, Piacentini J. Reduction of subjective distress in CBT for childhood OCD: nature of change, predictors, and relation to treatment outcome. J Anxiety Disord. 2014;28(2):125–132.
  • Foa EB, Kozak MJ. Emotional processing of fear: exposure to corrective information. Psychol Bull. 1986;99(1):20–35.
  • Arch JJ, Abramowitz JS. Exposure therapy for obsessive–compulsive disorder: an optimizing inhibitory learning approach. J Obsessive Compuls Relat Disord. 2015;6:174–182.
  • Abramowitz JS, Arch JJ. Strategies for improving long-term outcomes in cognitive behavioral therapy for obsessive-compulsive disorder: insights from learning theory. Cogn Behav Pract. 2014;21(1):20–31.
  • Culver NC, Vervliet B, Craske MG. Compound extinction: using the rescorla-wagner model to maximize exposure therapy effects for anxiety disorders. Clin Psychol Sci. 2015;3(3):335–348.
  • Kircanski K, Lieberman MD, Craske MG. Feelings into words: contributions of language to exposure therapy. Psychol Sci. 2012;23(10):1086–1091.
  • Deacon B, Kemp JJ, Dixon LJ, et al. Maximizing the efficacy of interoceptive exposure by optimizing inhibitory learning: a randomized controlled trial. Behav Res Ther. 2013;51(9):588–596.
  • Drysdale A, Hartley C, Pattwell S, et al. Fear and anxiety from principle to practice: implications for when to treat youth with anxiety disorders. Biol Psychiatry. 2014;75(11):e19–e20.
  • Mash EJ, Hunsley J. Evidence-based assessment of child and adolescent disorders: issues and challenges. J Clin Child Adolesc Psychol. 2005;34(3):362–379.
  • McGuire JF, Lewin AB, Geller DA, et al. Advances in the treatment of pediatric obsessive-compulsive disorder: rationale and design for the evaluation of D-cycloserine with exposure and response prevention. Neuropsychiatry. 2012;2(4):291–300.
  • LeDoux JE. Coming to terms with fear. Proc Natl Acad Sci. 2014;111(8):2871–2878.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.